BIOMEA FUSION ANNOUNCES COMPLETION OF ENROLLMENT IN COVALENT-211 PHASE II TRIAL OF ICOVAMENIB IN INSULIN-DEFICIENT TYPE 2 DIABETES

Reuters · 2d ago

Please log in to view news